menopause glp-1 Let's Talk Medical Advisory Board member Rekha Kumar, M.D., shares her expertise in a new Forbes Health article exploring how hormonal changes can affect weight and metabolic health during the menopause Menopause and GLP-1 Weight Loss:

Sermorelin is a synthetic analog of the first 29 amino acids of endogenous human growth hormone-releasing hormone (GHRH 1-29)

Higher dose of semaglutide increases weight loss, metabolic benefits Tripling the standard amount could safely treat patients with greater weight reduction goals, clinical trial led by UTSW researcher shows DALLAS Sept

The follow-on BALANCE Model (Medicare Part D launch January 2027) will further expand coverage with integrated lifestyle support requirements

Freezing lyophilized powder is generally safe and extends shelf life significantly

The first such GLP-1 agonist was approved by the FDA in 2005